PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28464042-4	2017	Patients in each of the two study groups were randomized to receive 90 mg qd of the cyclooxygenase-2 inhibitor etoricoxib for six months, two weeks or to a control arm, respectively.	Etoricoxib	111-121	prostaglandin-endoperoxide synthase 2	Homo sapiens	84-100